Abstract:Induced pluripotent stem cells (iPSC) that are generated from adult somatic cells are induced to express genes that make them pluripotent through reprogramming techniques, which may open up new possibilities for regenerative medicine to treat diseases in the future. Biotechnological, chemical, and physical modulation techniques are different reprogramming cell technologies to obtain iPSC and present their respective strengths in iPSC reprogramming‐based regenerative therapies, such as hair follicle defects, myocardial infarction, neurological disorders, liver diseases, and spinal cord injuries. Induced pluripotent stem cells (iPSCs) that are generated from adult somatic cells are induced to express genes that make them pluripotent through reprogramming techniques. With their unlimited proliferative capacity and multifaceted differentiation potential and circumventing the ethical problems encountered in the application of embryonic stem cells (ESC), iPSCs have a broad application in the fields of cell therapy, drug screening, and disease models and may open up new possibilities for regenerative medicine to treat diseases in the future. In this review, we begin with different reprogramming cell technologies to obtain iPSCs, including biotechnological, chemical, and physical modulation techniques, and present their respective strengths, and limitations, as well as the recent progress of research. Secondly, we review recent research advances in iPSC reprogramming‐based regenerative therapies. iPSCs are now widely used to study various clinical diseases of hair follicle defects, myocardial infarction, neurological disorders, liver diseases, and spinal cord injuries. This review focuses on the translational clinical research around iPSCs as well as their potential for growth in the medical field. Finally, we summarize the overall review and look at the potential future of iPSCs in the field of cell therapy as well as tissue regeneration engineering and possible problems. We believe that the advancing iPSC research will help drive long‐awaited breakthroughs in cellular therapy.

Hematopoietic stem cells from induced pluripotent stem cells – considering the role of microRNA as a cell differentiation regulator

Inducing Pluripotency for Disease Modeling, Drug Development and Craniofacial Applications.

Advances in Reprogramming of Peripheral Blood Cells to Induced Pluripotent Stem Cells

Improving the Reprogramming Efficiency of Somatic Cells to Induced Pluripotent Stem Cells.

Two Effective Routes For Removing Lineage Restriction Roadblocks: From Somatic Cells To Hepatocytes

Reprogramming stem cells in regenerative medicine

miRNAs involved in the generation, maintenance, and differentiation of pluripotent cells

Long noncoding RNAs in induced pluripotent stem cells and their differentiation

Progress in the Reprogramming of Somatic Cells

Cellular Reprogramming Using Defined Factors and MicroRNAs

Stem Cell Therapy and Immunological Rejection in Animal Models

Can Controlled Cellular Reprogramming Be Achieved Using Micrornas?

Current advances in the generation of human iPS cells: implications in cell-based regenerative medicine

Role of Microrna in Induced Pluripotent Stem Cell

Application of Modified mRNA in Somatic Reprogramming to Pluripotency and Directed Conversion of Cell Fate

Application of Induced Pluripotent Stem Cell-Derived Models for Investigating microRNA Regulation in Developmental Processes

Human Induced Pluripotent Stem Cells: From Cell Origin, Genomic Stability, and Epigenetic Memory to Translational Medicine

Understanding and Modulating Immunity With Cell Reprogramming

MicroRNAs in somatic cell reprogramming.

Immune cells and RBCs derived from human induced pluripotent stem cells: method, progress, prospective challenges

Hematopoietic Cells from Pluripotent Stem Cells: Hope and Promise for the Treatment of Inherited Blood Disorders